Pharmacological profiling of intravenous MP-04: sustained NAD+ augmentation, immune modulation, and renal protection in preclinical models.
Saved in:
| Title: | Pharmacological profiling of intravenous MP-04: sustained NAD+ augmentation, immune modulation, and renal protection in preclinical models. |
|---|---|
| Authors: | Ghosh A; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, United States., Pranesh G; MitoPower, LLC, Palo Alto, CA, United States., Zachariah N; MitoPower, LLC, Palo Alto, CA, United States., Murakami E; MitoPower, LLC, Palo Alto, CA, United States., Heredia A; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, United States., Mathur P; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, United States., Burns-Naas LA; Magnolia Toxicology Consulting, Limited Liability Company, Michigan, MI, United States., Weng S; MitoPower, LLC, Palo Alto, CA, United States., Ramanathan A; Institute for Stem Cell Science and Regenerative Medicine (InStem), Bangalore, India., Kottilil S; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, United States., Subramanian GM; MitoPower, LLC, Palo Alto, CA, United States. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2026 Jun 10; Vol. 17, pp. 1832979. Date of Electronic Publication: 2026 Jun 10 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
